Bristol/Sanofi Plavix Sales Triple In U.S.; Avapro Doubles

Sanofi-Synthelabo is planning an aggressive clinical trial program to expand labeling for its pair of cardiovascular products co-promoted with Bristol-Myers Squibb in the U.S., Plavix and Avapro.